|Articles|May 1, 2002
Glaucoma drug lowers IOP for up to 84 hours, study finds
Morrow, GA-Effective treatment of open-angle glaucoma requires not only the lowering of IOP but maintenance of the low pressure around the clock.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
2
Treating myopia today: US-focused treatments, challenges, and global insights
3
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
4
FDA clears BVI’s FineVision HP trifocal IOL for the US market
5